71/100 B+ · Elevated risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

AFFYMAX INC

Active operating 📍 cupertino, ca 2834

operating · RC 0001158223

B+

Overview

AFFYMAX INC is a operating registered in CUPERTINO, CA, United States. The company operates in the 2834 sector. With reported revenue of 1.4M USD in 2013. Its TraceComp score of 71 (B+) indicates moderate risk with some areas to watch.

Company Information

Registration Number
0001158223
Legal Form
operating
Address
cupertino, ca

Financial Profile

Latest filed accounts: FY 2013 · most recent available in public filings

Revenue (2013) 1,369,000 USD
Net Income -1,059,000 USD
Total Assets 7,443,000 USD
Altman Z -0.49 distress

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

No officers on record.

Research Output

Active research organization. 612 publications · 352,500 citations · h-index 222 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Biochemistry, Genetics and Molecular Biology (58%) · Medicine (25%) · Chemistry (12%).

See full research profile — top researchers & publications →

Source: OpenAlex (CC0). Objective publication & citation counts.

Patent Portfolio

Active patent holder. 23 patents · 11 active · 23 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • Net loss reported in FY 2013
  • Altman Z-Score in the distress zone — elevated insolvency risk on the model

Data Sources & Freshness

Data sourced from: bulk register.